Search - tctmd.com

Displaying 221 - 240 of 4998

Sort: Relevancy | Date

Presentation TCT 2016

Detecting and Differentiating Plaque Erosion vs Rupture and Does It Matter?

Presenter: John A. Ambrose, Peter H. Stone, Giulio Guagliumi

November 01, 2016

Presentation TCT 2016

2016 STEMI PCI Update: Evidence and Guidelines

Presenter: Sripal Bangalore, George D. Dangas, Sanjit S. Jolly

November 01, 2016

Presentation TCT 2016

Case Introduction: How Would You Revascularize This Patient?

Presenter: John D. Puskas, Gregg W. Stone, Michael E. Halkos

November 01, 2016

Presentation TCT 2016

Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal

Presenter: John A. Ambrose, Peter H. Stone, Guillermo Tearney

November 01, 2016

Presentation TCT 2016

Announcing the NIH-sponsored HYBRID Revascularization Trial

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

2016 DAPT Update: Evidence and Guidelines

Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla

November 01, 2016

Presentation TCT 2016

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying

Presenter: John A. Ambrose, Peter H. Stone, David Erlinge

November 01, 2016

Presentation TCT 2016

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Presenter: Sripal Bangalore, George D. Dangas, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Presenter: John A. Ambrose, Peter H. Stone

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations

Presenter: John D. Puskas, Gregg W. Stone, John S. Douglas Jr

November 01, 2016

Presentation TCT 2016

The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer

Presenter: John A. Ambrose, Peter H. Stone, James E. Muller

November 01, 2016

Presentation TCT 2016

Bioabsorbable Vascular Scaffolds: Landscape in 2016

Presenter: Sripal Bangalore, George D. Dangas, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI!

Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Gennaro Giustino

November 01, 2016

Presentation TCT 2016

CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist

Presenter: Somjot S. Brar, Richard Solomon, Anand Prasad

November 01, 2016

Presentation TCT 2016

ACS and Pharmacotherapy Guidelines Update

Presenter: George D. Dangas, Debabrata Mukherjee, John A. Bittl

November 01, 2016

Presentation TCT 2016

Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies

Presenter: George D. Dangas, Debabrata Mukherjee, C. Michael Gibson

November 01, 2016

Presentation TCT 2016

Deciding on the Duration of DAPT

Presenter: George D. Dangas, Debabrata Mukherjee, Neal S. Kleiman

November 01, 2016

Presentation TCT 2016

TCT 320: The Results of T-Provisional and Mini Crush Stenting in Patients with Bifurcation Lesions After Recanalization of Chronic coronary Arteries Occlusions. Comparative Analysis

Presenter: Michael A. Kutcher, Issam D. Moussa

November 01, 2016

Presentation TCT 2016

TCT 359: Ulnar Artery Transient Compression Facilitating Radial Artery patent hemostasis (ULTRA). A Novel Technique to Reduce Radial Artery Occlusion

Presenter: Ivo Bernat, Thomas M. Tu

November 01, 2016

Advertisement

Detecting and Differentiating Plaque Erosion vs Rupture and Does It Matter?

2016 STEMI PCI Update: Evidence and Guidelines

Case Introduction: How Would You Revascularize This Patient?

Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal

Announcing the NIH-sponsored HYBRID Revascularization Trial

2016 DAPT Update: Evidence and Guidelines

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations

The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer

Bioabsorbable Vascular Scaffolds: Landscape in 2016

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI!

CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist

ACS and Pharmacotherapy Guidelines Update

Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies

Deciding on the Duration of DAPT

TCT 320: The Results of T-Provisional and Mini Crush Stenting in Patients with Bifurcation Lesions After Recanalization of Chronic coronary Arteries Occlusions. Comparative Analysis

TCT 359: Ulnar Artery Transient Compression Facilitating Radial Artery patent hemostasis (ULTRA). A Novel Technique to Reduce Radial Artery Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content